Please login to the form below

Not currently logged in
Email:
Password:

contraception

This page shows the latest contraception news and features for those working in and with pharma, biotech and healthcare.

'Femtech' poised to explode, with applications set to trigger healthcare disruption

'Femtech' poised to explode, with applications set to trigger healthcare disruption

The consultants say the market, which could be worth $50bn by 2025, has already seen a number of innovations, including European CE approval for the first mobile application for contraception in

Latest news

More from news
Approximately 13 fully matching, plus 67 partially matching documents found.

Latest Intelligence

  • Immunisation politicised Immunisation politicised

    contraception research and development.

  • The pill branding The pill branding

    In Eastern Europe and Belarus, the positioning rather targets the topic of escape, and in Latin American countries, the brands focus on the very neutral topic of contraception. ... Naming and branding recommendations. Drawing on a branding study we

  • Designing unique patient solutions in rare disease Designing unique patient solutions in rare disease

    She has worked across a range of therapy areas including Psoriasis, Oral Contraception and MS.

  • Pharma deals during June 2013 Pharma deals during June 2013

    Bayer closed its acquisition of Conceptus, securing access to Essure, a non-surgical method of birth control, which extends Bayer's franchise in contraception.

  • Pharma deals during January 2013 Pharma deals during January 2013

    This acquisition brings with it an IUD for long term contraception (pending approval in Europe and phase III in the US) and Daifert an immunoassay kit for in vitro fertilisation. ... Uteron Pharma / Watson. Acquisition. Contraception fertility. 305.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Adelphi Research UK

Adelphi Research UK is a healthcare insight partner. We uniquely blend robust market research with a consultancy approach, to guide...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics